The CardioMetabo assessment permitted us to newly diagnose 2 IMD: 1 patient with Fabry disease and 1 patient with short-chain acyl-CoA dehydrogenase (SCAD) deficiency. This evidence concerns the gene ACADS and short chain acyl-CoA dehydrogenase deficiency.